Cargando…

A Comprehensive Analysis of Programmed Cell Death-Associated Genes for Tumor Microenvironment Evaluation Promotes Precise Immunotherapy in Patients with Lung Adenocarcinoma

Immune checkpoint inhibitors (ICIs) represent a new hot spot in tumor therapy. Programmed cell death has an important role in the prognosis. We explore a programmed cell death gene prognostic model associated with survival and immunotherapy prediction via computational algorithms. Patient details we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yunxi, Ouyang, Wenhao, Wang, Zehua, Huang, Hong, Ou, Qiyun, Lin, Ruichong, Yu, Yunfang, Yao, Herui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10058589/ https://www.ncbi.nlm.nih.gov/pubmed/36983658 http://dx.doi.org/10.3390/jpm13030476

Ejemplares similares

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma
por: Ouyang, Wenhao, et al.
Publicado: (2022)

Immune gene patterns and characterization of the tumor immune microenvironment associated with cancer immunotherapy efficacy
por: Lin, Lili, et al.
Publicado: (2023)

Association of Long Noncoding RNA Biomarkers With Clinical Immune Subtype and Prediction of Immunotherapy Response in Patients With Cancer
por: Yu, Yunfang, et al.
Publicado: (2020)

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non–Small Cell Lung Cancer: A Meta-analysis and Individual Patient–Level Analysis
por: Yu, Yunfang, et al.
Publicado: (2019)

Association of Immune Checkpoint Inhibitor Therapy With Survival in Patients With Cancers With MUC16 Variants
por: Yu, Yunfang, et al.
Publicado: (2020)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

Association of survival and genomic mutation signature with immunotherapy in patients with hepatocellular carcinoma
por: Ou, Qiyun, et al.
Publicado: (2020)

Joint association of patients’ sex and PD‐L1 expression with overall survival benefits and tumor‐immune microenvironment in immune checkpoint inhibitors for cancers
por: Li, Anlin, et al.
Publicado: (2020)

Comprehensive Analysis of Programmed Cell Death Signature in the Prognosis, Tumor Microenvironment and Drug Sensitivity in Lung Adenocarcinoma
por: Pan, Shize, et al.
Publicado: (2022)

Tumor microenvironment evaluation promotes precise checkpoint immunotherapy of advanced gastric cancer
por: Zeng, Dongqiang, et al.
Publicado: (2021)

Association of immune checkpoint inhibitor with survival in patients with cancers with protein tyrosine phosphatase receptor T mutation
por: He, Zifan, et al.
Publicado: (2020)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Modelling the tumor immune microenvironment for precision immunotherapy
por: Mackenzie, Nathan J, et al.
Publicado: (2022)

Tumor microenvironment-associated lactate metabolism regulates the prognosis and precise checkpoint immunotherapy outcomes of patients with lung adenocarcinoma
por: Qiu, Song, et al.
Publicado: (2022)

Comprehensive analysis of m6A regulators and relationship with tumor microenvironment, immunotherapy strategies in colorectal adenocarcinoma
por: Ji, Jian, et al.
Publicado: (2023)

The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy
por: Tang, Yun-Qiang, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects
por: Li, Ke-Yu, et al.
Publicado: (2020)

Tumor microenvironment in pancreatic ductal adenocarcinoma: Implications in immunotherapy
por: Smith, Caitlyn, et al.
Publicado: (2022)

Immunotherapy response and microenvironment provide biomarkers of immunotherapy options for patients with lung adenocarcinoma
por: Zhan, Xue, et al.
Publicado: (2022)

Comprehensive Analysis of 5-Methylcytosine (m(5)C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy
por: Wang, Ronglin, et al.
Publicado: (2022)

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study
por: Yu, Yunfang, et al.
Publicado: (2021)

Cell Death in the Tumor Microenvironment: Implications for Cancer Immunotherapy
por: Gadiyar, Varsha, et al.
Publicado: (2020)

Novel blood‐based tumor mutation algorithm and nomogram predict survival of immune checkpoint inhibitor in non‐small‐cell lung cancer: Results from two multicenter, randomized clinical trials
por: Yu, Yunfang, et al.
Publicado: (2020)

Pancreatic ductal adenocarcinoma: Treatment hurdles, tumor microenvironment and immunotherapy
por: Sarantis, Panagiotis, et al.
Publicado: (2020)

Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
por: Kuang, Junjie, et al.
Publicado: (2023)

Machine learning radiomics of magnetic resonance imaging predicts recurrence-free survival after surgery and correlation of LncRNAs in patients with breast cancer: a multicenter cohort study
por: Yu, Yunfang, et al.
Publicado: (2023)

A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma
por: Zhang, Yi, et al.
Publicado: (2023)

Signatures of Multi-Omics Reveal Distinct Tumor Immune Microenvironment Contributing to Immunotherapy in Lung Adenocarcinoma
por: Huang, Ziqi, et al.
Publicado: (2021)

Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
por: Hoshimoto, Aitoshi, et al.
Publicado: (2023)

Comprehensive analyses of one-carbon metabolism related genes and their association with prognosis, tumor microenvironment, chemotherapy resistance and immunotherapy in lung adenocarcinoma
por: Zhou, Ning, et al.
Publicado: (2022)

Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma
por: Cui, Yingshu, et al.
Publicado: (2023)

Ferroptosis-Related lncRNAs Act as Novel Prognostic Biomarkers in the Gastric Adenocarcinoma Microenvironment, Immunotherapy, and Chemotherapy
por: Zheng, Yushi, et al.
Publicado: (2023)

Breast cancer immunology and immunotherapy: targeting the programmed cell death protein-1/programmed cell death protein ligand-1
por: Zhao, Jing, et al.
Publicado: (2020)

Comprehensive Analysis of PPMs in Pancreatic Adenocarcinoma Indicates the Value of PPM1K in the Tumor Microenvironment
por: Zhuang, Yanyan, et al.
Publicado: (2023)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Comprehensive analysis of diverse programmed cell death patterns in the prognosis, tumor microenvironment and drug sensitivity in hepatocellular carcinoma
por: Yu, Youlin, et al.
Publicado: (2023)

Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients
por: Wang, Zhe, et al.
Publicado: (2021)

Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma
por: Chen, Xi, et al.
Publicado: (2022)

Comprehensive Analysis of APA Events and Their Association With Tumor Microenvironment in Lung Adenocarcinoma
por: Zhang, Yuchu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ubkkuape1vf3msksro4poubd75